GHP Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.69M Buy
34,602
+215
+0.6% +$56.5K 0.36% 88
2026
Q1
$9.17M Sell
34,387
-354
-1% -$95.9K 0.38% 89
2025
Q4
$8.72M Sell
34,741
-826
-2% -$219K 0.36% 95
2025
Q3
$10.2M Sell
35,567
-1,507
-4% -$404K 0.43% 80
2025
Q2
$9.73M Sell
37,074
-1,695
-4% -$413K 0.43% 79
2025
Q1
$9.02M Buy
38,769
+1,695
+5% +$411K 0.43% 84
2024
Q4
$8.5M Buy
37,074
+1,577
+4% +$362K 0.4% 93
2024
Q3
$7.93M Buy
35,497
+1,117
+3% +$246K 0.36% 102
2024
Q2
$7M Buy
34,380
+2,151
+7% +$438K 0.35% 105
2024
Q1
$7.04M Buy
32,229
+799
+3% +$176K 0.35% 108
2023
Q4
$7.14M Buy
31,430
+619
+2% +$130K 0.39% 91
2023
Q3
$6.21M Sell
30,811
-4,222
-12% -$891K 0.38% 98
2023
Q2
$6.56M Buy
35,033
+1,414
+4% +$274K 0.38% 95
2023
Q1
$6.63M Buy
33,619
+465
+1% +$95.7K 0.42% 81
2022
Q4
$6.71M Sell
33,154
-1,285
-4% -$251K 0.45% 78
2022
Q3
$6.06M Buy
34,439
+1,168
+4% +$239K 0.47% 74
2022
Q2
$6.7M Buy
33,271
+1,927
+6% +$411K 0.5% 60
2022
Q1
$7.1M Buy
31,344
+3,240
+12% +$762K 0.47% 69
2021
Q4
$7.59M Buy
28,104
+3,414
+14% +$845K 0.54% 59
2021
Q3
$5.97M Buy
24,690
+1,867
+8% +$471K 0.47% 82
2021
Q2
$5.41M Buy
22,823
+1,850
+9% +$422K 0.44% 90
2021
Q1
$4.59M Buy
20,973
+1,168
+6% +$234K 0.4% 93
2020
Q4
$3.46M Buy
19,805
+785
+4% +$136K 0.33% 112
2020
Q3
$3.08M Buy
19,020
+1,316
+7% +$209K 0.35% 104
2020
Q2
$2.53M Buy
17,704
+896
+5% +$124K 0.31% 112
2020
Q1
$1.82M Sell
16,808
-839
-5% -$121K 0.27% 117
2019
Q4
$2.56M Buy
17,647
+244
+1% +$35.2K 0.28% 113
2019
Q3
$2.51M Buy
17,403
+105
+0.6% +$15.3K 0.31% 108
2019
Q2
$2.57M Buy
17,298
+468
+3% +$65.3K 0.31% 113
2019
Q1
$2.21M Buy
16,830
+203
+1% +$25K 0.29% 120
2018
Q4
$1.8M Sell
16,627
-603
-3% -$80.8K 0.27% 124
2018
Q3
$2.57M Buy
17,230
+775
+5% +$118K 0.34% 94
2018
Q2
$2.54M Buy
16,455
+1,111
+7% +$168K 0.36% 90
2018
Q1
$2.13M Buy
15,344
+646
+4% +$94.9K 0.3% 104
2017
Q4
$2.01M Buy
14,698
+1,684
+13% +$223K 0.29% 110
2017
Q3
$1.69M Buy
13,014
+635
+5% +$84.7K 0.26% 120
2017
Q2
$1.64M Buy
12,379
+1,373
+12% +$168K 0.26% 112
2017
Q1
$1.36M Buy
11,006
+1,304
+13% +$154K 0.23% 124
2016
Q4
$1.07M Buy
9,702
+1,234
+15% +$137K 0.2% 145
2016
Q3
$1M Buy
8,468
+372
+5% +$43.8K 0.2% 142
2016
Q2
$906K Buy
8,096
+530
+7% +$57K 0.2% 146
2016
Q1
$761K Buy
7,566
+663
+10% +$63.6K 0.17% 156
2015
Q4
$733K Buy
6,903
+649
+10% +$67K 0.18% 150
2015
Q3
$583K Buy
6,254
+1,257
+25% +$130K 0.15% 164
2015
Q2
$525K Buy
4,997
+2,846
+132% +$296K 0.13% 177
2015
Q1
$233K Buy
+2,151
New +$221K 0.06% 250

Other funds holding LH

GHP Investment Advisors's LH Position: Q2 2026 in Review

GHP Investment Advisors increased its Labcorp (LH) stake by 0.63% in Q2 2026, buying an estimated $56.5K and bringing the position to 34,602 shares worth $9.69M. The position accounts for 0.36% of the portfolio, ranked #88.

GHP Investment Advisors first reported a position in LH in Q1 2015 and has held it in 46 quarters since. The position peaked at $10.2M in Q3 2025. 381 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • GHP Investment Advisors held 34,602 shares of Labcorp worth $9.69M as of Q2 2026.
  • GHP Investment Advisors bought 215 Labcorp shares in Q2 2026, an estimated $56.5K.
  • Labcorp made up 0.36% of GHP Investment Advisors's portfolio in Q2 2026, its #88 holding.
  • GHP Investment Advisors first reported a position in Labcorp in Q1 2015 and has held it in 46 quarters since.
  • GHP Investment Advisors's Labcorp position peaked at $10.2M in Q3 2025.
  • 381 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.